跳至主要内容
临床试验/KCT0005747
KCT0005747招募中未知

A multicenter retrospective registry to perform the REal world efficacy of Clinical Outcome and adverse left ventricular Remodeling in patients with heart failure with reDuced ejection fraction treated with Sacubitril/Valsartan (RECORD-SV)

Soon Chun Hyang University Hospital Bucheon0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • 1) All patients aged 18 years of age or older with reduced LV systolic function (LVEF=40%) are targeted
  • 2) Patients who are taking Sacubitril/valsartan or who are taking conventional ACEi/ARB oral medications and have been replaced with Sacubitril/valsartan.

排除标准

  • 1) Severe shock or hypotension at registration
  • 2) Those who have a history of angioedema
  • 3) Those who have hypersensitivity reactions and side effects to ACE inhibitors, ARB, and NEP inhibitors
  • 4) Patients who are pregnant or may become pregnant
  • 5) Patients with cancer history within 5 years

研究者

发起方
Soon Chun Hyang University Hospital Bucheon

相似试验

The clinical effect of Sacubitril / Valsartan in... | 临床试验